Sacituzumab Govitecan Treats Metastatic Triple-Negative Breast Cancer
Progression-free, overall survival prolonged with sacitizumab govitecan versus single-agent chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.